BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 19187350)

  • 1. The BJUI's clinical trials initiative.
    Davis JW; MacLennan G
    BJU Int; 2017 Apr; 119(4):503. PubMed ID: 28319352
    [No Abstract]   [Full Text] [Related]  

  • 2. Are the National Institute for Health and Clinical Excellence guidelines that promulgate active surveillance for low-risk prostate cancer justified by the available evidence?
    Kirby RS; Fitzpatrick JM
    BJU Int; 2008 Dec; 102(11):1492-3. PubMed ID: 19035856
    [No Abstract]   [Full Text] [Related]  

  • 3. Prostate cancer in Spain: from guidelines to clinical practice.
    Alcaraz A; Burgos FJ; Cózar JM; Gómez-Veiga F; Morote J; Solsona E; Unda M; Carballido J
    BJU Int; 2011 Jul; 108(1):61-6. PubMed ID: 21223474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Groups aim for trustworthy clinical practice guidelines.
    Mitka M
    JAMA; 2014 Mar; 311(12):1187-8. PubMed ID: 24668083
    [No Abstract]   [Full Text] [Related]  

  • 5. NICE Guidelines for AAA Repair: An Enigma.
    Sultan S; Veith FJ; Ascher E; Ouriel K; Hynes N
    J Endovasc Ther; 2020 Oct; 27(5):869-870. PubMed ID: 32659137
    [No Abstract]   [Full Text] [Related]  

  • 6. Are the National Institute for Health and Clinical Excellence guidelines that promulgate active surveillance for low-risk prostate cancer justified by the available evidence?
    Parker C; Graham J
    BJU Int; 2009 Feb; 103(4):554. PubMed ID: 19187350
    [No Abstract]   [Full Text] [Related]  

  • 7. Prostate cancer: Prudent practice optimizes screening outcomes.
    Auvinen A
    Nat Rev Urol; 2016 Jul; 13(7):376-7. PubMed ID: 27215425
    [No Abstract]   [Full Text] [Related]  

  • 8. Focal therapy of prostate cancer: evidence-based analysis for modern selection criteria.
    Abern MR; Tsivian M; Polascik TJ
    Curr Urol Rep; 2012 Apr; 13(2):160-9. PubMed ID: 22298223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NICE: guessing is not guidance. National Institute for Clinical Excellence.
    Poole-Wilson PA
    Heart; 2002 Jun; 87(6):510-2. PubMed ID: 12010929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The critical role of the pathologist in determining eligibility for active surveillance as a management option in patients with prostate cancer: consensus statement with recommendations supported by the College of American Pathologists, International Society of Urological Pathology, Association of Directors of Anatomic and Surgical Pathology, the New Zealand Society of Pathologists, and the Prostate Cancer Foundation.
    Amin MB; Lin DW; Gore JL; Srigley JR; Samaratunga H; Egevad L; Rubin M; Nacey J; Carter HB; Klotz L; Sandler H; Zietman AL; Holden S; Montironi R; Humphrey PA; Evans AJ; Epstein JI; Delahunt B; McKenney JK; Berney D; Wheeler TM; Chinnaiyan AM; True L; Knudsen B; Hammond ME
    Arch Pathol Lab Med; 2014 Oct; 138(10):1387-405. PubMed ID: 25092589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence-based recommendations for spine surgery.
    Fisher CG; Vaccaro AR; Patel AA; Prasad SK; Chi J; Mulpuri K; Thomas KC; Whang PG
    Spine (Phila Pa 1976); 2015 Mar; 40(5):E309-16. PubMed ID: 25901985
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.